Immunotherapy: Open access is a peer reviewed journal has started accepting articles for its upcoming issue which is Volume 5 and Issue 1. Journal accepts articles related to Immunology, Cancer immunotherapy, Auto immune disorders, Immunity, Allergy immunotherapy, cancer, sublingual immunotherapy etc.

Journal follows the fast-track peer review process with rapid peer review process with highly esteemed professors, research scientist as editors and reviewers. Journal aims to disseminate novel findings and reviews along with short communications, commentaries, image articles and reviews. Author can submit articles through an email to editorial office at immunothe@immunologyres.com or can be done at journal homepage at https://www.longdom.org/submissions/immunotherapy-open-access.html

Immunotherapy: Open access is having NLM ID: 101676003 and ISSN: 2471-9552. Journal is having PubMed ID which helps the authors who are having NIH grants can directly index their articles in PubMed. Articles also have been assigned with DOI link (Digital Object Identification) such that articles can be easily accessible to author.

As the journal belongs to open access it is easily accessible to everyone and the article views and citations will also be good. The citations report for each and every article was provided at homepage of the journal at https://www.longdom.org/immunotherapy/citations.html

All works published by Longdom Publishing SL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Immunotherapy: Open Access strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Immunotherapy: Open Access Journal will keep up-to- date with latest advances in the field of immunotherapy. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Immunotherapy: Open Access are freely accessible to everyone immediately after publication. The Journal supports the Bethesda Statement on Open Access Publishing.

Longdom group also conducts conferences all over the world with eminent speakers. The abstracts submitted by them in that conference will be released in journals according to the subject of conference.

Contact details:

Sarah Eve
Managing Editor
Immunotherapy: Open Access
Whatsapp No:  +1-504-608-2390
Email: immunother@emedsci.com